Abraham Edathara C, Huaqian Jin, Aziz Atya, Kumarasamy Anbarasu, Datta Poppy
Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 516, Little Rock, AR 72205, USA.
Mol Cell Biochem. 2008 Mar;310(1-2):235-9. doi: 10.1007/s11010-007-9685-1. Epub 2007 Dec 25.
Earlier studies have shown significant loss of chaperone activity in alpha-crystallin from diabetic lenses. In vitro glycation studies have suggested that glycation of alpha-crystallin could be the major cause of chaperone activity loss. The following lysine (K) residues in alpha-crystallin have been identified as the major glycation sites: K11, K78, and K166 in alpha A-crystallin and K90, K92, and K166 in alpha B-crystallin. The present study was aimed to assess the contribution of each of the above glycation site in the overall glycation and loss of chaperone activity by mutating them to threonine followed by in vitro glycation with fructose. Level of glycated protein (GP) was determined by phenylboronate affinity chromatography, advanced glycation end products (AGEs) by direct ELISA using anti-AGE polyclonal antibody, and chaperone activity by using alcohol dehydrogenase as the target protein. K11T, K78, and K166T mutants of alpha A showed 33, 17, and 27% decrease in GP and 32, 18, and 21% decrease in AGEs, respectively, as compared to alpha A-wt. Likewise, K90T, K92T, K90T/K92T, and K166T mutants of alpha B showed 18, 21, 29, and 12% decrease in GP and 22, 24, 32, and 16% decrease in AGEs, respectively. Chaperone activity also showed concomitant increase with decreasing glycation and AGEs formation. alpha A-K11T and alpha B-K90T/K92T mutants showed the largest decrease in glycation and increase in chaperone activity.
早期研究表明,糖尿病晶状体中的α-晶状体蛋白伴侣活性显著丧失。体外糖基化研究表明,α-晶状体蛋白的糖基化可能是伴侣活性丧失的主要原因。已确定α-晶状体蛋白中的以下赖氨酸(K)残基为主要糖基化位点:αA-晶状体蛋白中的K11、K78和K166,以及αB-晶状体蛋白中的K90、K92和K166。本研究旨在通过将上述每个糖基化位点突变为苏氨酸,然后用果糖进行体外糖基化,来评估它们在整体糖基化和伴侣活性丧失中的作用。通过苯基硼酸亲和色谱法测定糖化蛋白(GP)水平,使用抗AGE多克隆抗体通过直接ELISA测定晚期糖基化终产物(AGEs),并以乙醇脱氢酶作为靶蛋白测定伴侣活性。与αA-wt相比,αA的K11T、K78和K166T突变体的GP分别降低了33%、17%和27%,AGEs分别降低了32%、18%和21%。同样,αB的K90T、K92T、K90T/K92T和K166T突变体的GP分别降低了18%、21%、29%和12%,AGEs分别降低了22%、24%、32%和16%。伴侣活性也随着糖基化和AGEs形成的减少而相应增加。αA-K11T和αB-K90T/K92T突变体的糖基化降低幅度最大,伴侣活性增加幅度最大。